Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 104.97

+0.8%

11:31 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	2/29/2012 7:15:04 AM
	Read Replies (1) of 3202

150 million upfront...... Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases Selective JAK1 inhibitor in Phase II clinical development for rheumatoid arthritis Abbott to Retain Exclusive Global Commercial Rights with Galapagos co- promotion in Benelux Countries Galapagos to Receive Upfront Payment of $150 Million, with the Potential for Significant Milestone Payments Galapagos to host webcast presentation today at 4 pm CET/ 10am Eastern US/ 7 am Pacific finance.yahoo.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next